Cargando…
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin and a cholesterol-lowering statin. However, both drugs act on glucose and lipid metabolism which could lead to adverse effects when used...
Autores principales: | van Stee, Mariël F., de Graaf, Albert A., Groen, Albert K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026339/ https://www.ncbi.nlm.nih.gov/pubmed/29960584 http://dx.doi.org/10.1186/s12933-018-0738-4 |
Ejemplares similares
-
Determination of physiological parameters for endogenous glucose production in individuals using diurnal data
por: van Stee, Mariël F., et al.
Publicado: (2019) -
Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals
por: Long, Douglas E., et al.
Publicado: (2022) -
Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023) -
Metabolic Action of Metformin
por: Szymczak-Pajor, Izabela, et al.
Publicado: (2022) -
Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)